Literature DB >> 11514397

Complete scanning of the hereditary hemochromatosis gene (HFE) by use of denaturing HPLC.

G Le Gac1, C Mura, C Férec.   

Abstract

BACKGROUND: Between 4% and 35% of hereditary hemochromatosis (HC) probands are C282Y or H63D heterozygotes or lack both of these two common HFE mutations, and 15 novel HFE mutations have been described recently. We evaluated denaturing HPLC (DHPLC) for screening of the whole HFE coding region and further defined whether HC probands with an incomplete HFE genotype carry uncommon mutations.
METHODS: Analytical conditions for each coding exon were determined by a combination of computer melting profile predictions and experimental melting curves. To test accuracy for scanning the complete HFE coding region and optimize DHPLC running conditions, each melting domain was investigated with at least one mutation or one polymorphism as reference. We tested 100 DNA samples harboring the C282Y, H63D, or S65C mutations and 17 artificially created positive controls that carried either 1 of the 14 other known HFE mutations or 3 selected polymorphisms.
RESULTS: Investigations on each of the coding exons 1, 2, 4, 5, and 6 could be performed at one analysis temperature. Coding exon 3 displayed a more complex melting profile and required two analysis temperatures. DHPLC detected all known HFE mutations as well as the three selected polymorphisms.
CONCLUSIONS: DHPLC can be used to scan the HFE gene in HC probands in whom at least one chromosome lacks an assigned mutation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514397

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.

Authors:  Ronald T Acton; James C Barton; Catherine Leiendecker-Foster; Christopher Zaun; Christine E McLaren; John H Eckfeldt
Journal:  Blood Cells Mol Dis       Date:  2010-02-23       Impact factor: 3.039

2.  Rapid screening mitochondrial DNA mutation by using denaturing high-performance liquid chromatography.

Authors:  Man-Ran Liu; Kai-Feng Pan; Zhen-Fu Li; Yi Wang; Da-Jun Deng; Lian Zhang; You-Yong Lu
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  Hepcidin messenger RNA expression in human lymphocytes.

Authors:  Jorge P Pinto; Vera Dias; Heinz Zoller; Graça Porto; Helena Carmo; Félix Carvalho; Maria de Sousa
Journal:  Immunology       Date:  2010-01-19       Impact factor: 7.397

4.  Impact of HFE genetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data.

Authors:  Virginie Scotet; Gérald Le Gac; Marie-Christine Mérour; Anne-Yvonne Mercier; Brigitte Chanu; Chandran Ka; Catherine Mura; Jean-Baptiste Nousbaum; Claude Férec
Journal:  BMC Med Genet       Date:  2005-06-01       Impact factor: 2.103

5.  Discrimination of three mutational events that result in a disruption of the R122 primary autolysis site of the human cationic trypsinogen (PRSS1) by denaturing high performance liquid chromatography.

Authors:  C Le Maréchal; J M Chen; I Quéré; O Raguénès; C Férec; J Auroux
Journal:  BMC Genet       Date:  2001-11-19       Impact factor: 2.797

6.  Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay.

Authors:  Marko Cukjati; Tomaz Vaupotic; Ruth Rupreht; Vladka Curin-Serbec
Journal:  BMC Med Genet       Date:  2007-11-23       Impact factor: 2.103

Review 7.  HFE gene variants, iron, and lipids: a novel connection in Alzheimer's disease.

Authors:  Fatima Ali-Rahmani; Cara-Lynne Schengrund; James R Connor
Journal:  Front Pharmacol       Date:  2014-07-08       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.